This inventor holds 1 USPTO granted patent. Top assignee: Exonhit Therapeutics, Sa. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Alma Viso Beronda: Innovator in Cell Proliferative Disease Treatment
Introduction
Alma Viso Beronda is a prominent inventor based in Madrid, Spain. She has made significant contributions to the pharmaceutical industry, particularly in the treatment of cell proliferative diseases. Her innovative work focuses on developing compounds that have the potential to combat various forms of cancer.
Latest Patents
Alma Viso Beronda holds a patent for "Compounds and methods of treating cell proliferative diseases." This invention relates to compounds that exhibit anti-proliferative activities. The patent outlines methods for treating diseases associated with abnormal cell proliferation, including cancer, by administering these compounds. Furthermore, it discusses pharmaceutical compositions that incorporate these compounds, which are particularly useful in cancer treatment.
Career Highlights
Alma is currently associated with Exonhit Therapeutics, S.A., where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies and the pharmaceutical landscape.
Collaborations
Alma has collaborated with notable colleagues, including Véronique Leblanc and Bertrand Leblond. These partnerships have contributed to her innovative research and the development of effective treatments.
Conclusion
Alma Viso Beronda is a trailblazer in the field of pharmaceuticals, with a focus on combating cell proliferative diseases. Her patent and ongoing work at Exonhit Therapeutics, S.A. highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile